New Technology Simplifies Fluid Management for Hysteroscopic Procedures
By HospiMedica International staff writers Posted on 29 Aug 2018 |
Image: The Fluent fluid management system (Photo courtesy of Hologic).
A novel management system provides operating room (OR) staff a more simplified and effective method for fluid control during hysteroscopic procedures.
The Hologic (Bedford, MA, USA) Fluent fluid management system is designed to both provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus while providing drive, control, and suction for hysteroscopic morcellators and a wide variety of other hysteroscopic devices. To simplify the surgical procedures, a single waste bag and unique FloPak technology are used to effectively control fluid use throughout the procedure.
An intuitive user interface helps optimize the operating room (OR) workflow, and also provides step-by-step instructions for setup, disassembly, and troubleshooting of the system. In addition, large visual and audible alerts monitor fluid deficit, pressure, low fluid bags, and full waste bags to help keep procedures moving as efficiently as possible. The system also has the ability to detect accurate fluid deficit within 50 mL. When running together with the proprietary MyoSure system, the Fluent system shows a change in average intrauterine pressure of less than one percent.
“Fluid management plays a vital role in gynecological procedures, yet there have been few advances in the technology,” said Edward Evantash, MD, medical director and vice president of global medical affairs at Hologic. “The Fluent system is changing the game in fluid management. Developed in response to the challenges facing nurses and doctors performing hysteroscopies, it combines a streamlined design with innovative technology for more efficient fluid monitoring during procedures.”
Morcellation involves minimally invasive surgical (MIS) fragmentation of the uterus into smaller pieces so as to facilitate its removal during hysteroscopic procedures. In May 2014, the U.S. Food and Drug Administration (FDA) issued a warning against using laparoscopic power morcellator devices in MIS to remove uterine fibroids, claiming that women undergoing the procedures carry a 1 in 350 risk of uterine sarcoma, and that morcellator tools could worsen the spread of cancerous tissue.
The Hologic (Bedford, MA, USA) Fluent fluid management system is designed to both provide liquid distension of the uterus during diagnostic and operative hysteroscopy, and to monitor the volume differential between the irrigation fluid flowing into and out of the uterus while providing drive, control, and suction for hysteroscopic morcellators and a wide variety of other hysteroscopic devices. To simplify the surgical procedures, a single waste bag and unique FloPak technology are used to effectively control fluid use throughout the procedure.
An intuitive user interface helps optimize the operating room (OR) workflow, and also provides step-by-step instructions for setup, disassembly, and troubleshooting of the system. In addition, large visual and audible alerts monitor fluid deficit, pressure, low fluid bags, and full waste bags to help keep procedures moving as efficiently as possible. The system also has the ability to detect accurate fluid deficit within 50 mL. When running together with the proprietary MyoSure system, the Fluent system shows a change in average intrauterine pressure of less than one percent.
“Fluid management plays a vital role in gynecological procedures, yet there have been few advances in the technology,” said Edward Evantash, MD, medical director and vice president of global medical affairs at Hologic. “The Fluent system is changing the game in fluid management. Developed in response to the challenges facing nurses and doctors performing hysteroscopies, it combines a streamlined design with innovative technology for more efficient fluid monitoring during procedures.”
Morcellation involves minimally invasive surgical (MIS) fragmentation of the uterus into smaller pieces so as to facilitate its removal during hysteroscopic procedures. In May 2014, the U.S. Food and Drug Administration (FDA) issued a warning against using laparoscopic power morcellator devices in MIS to remove uterine fibroids, claiming that women undergoing the procedures carry a 1 in 350 risk of uterine sarcoma, and that morcellator tools could worsen the spread of cancerous tissue.
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery